A phase III, multicentre, randomised, double-blinded, placebo-controlled clinical trial of SpironolacTOne and famciclovir in Progressive Multiple Sclerosis: the STOP-MS trial
- Broadley, Simon (Recipient), Sun, Jing (Recipient), Taylor, Bruce (Recipient), Barnett, Michael (Recipient), Chataway, Jeremy (Recipient), Parmar, Mahesh (Recipient), Steinman, Lawrence (Recipient), Tscharke, David Carl (Recipient), Kalincik, Tomas (Recipient), Jokubaitis, ilija (Recipient), Smith, Corey (Recipient), Campbell, Julie (Recipient), Li, Vivien (Recipient), Parnell, Grant (Recipient) & Ramanathan, Sudarshini (Recipient)
Prize: Grant › Successful